Independent and epistatic effects of variants in VPS10-d receptors on Alzheimer disease risk and processing of the amyloid precursor protein (APP).

TitleIndependent and epistatic effects of variants in VPS10-d receptors on Alzheimer disease risk and processing of the amyloid precursor protein (APP).
Publication TypeJournal Article
Year of Publication2013
AuthorsReitz C, Tosto G, Vardarajan B, Rogaeva E, Ghani M, Rogers RS, Conrad C, Haines JL, Pericak-Vance MA, Fallin MD, Foroud T, Farrer LA, Gerard D Schellenberg, George-Hyslop PS, Mayeux R
Corporate AuthorsAlzheimer's Disease Genetics Consortium(ADGC)
JournalTransl Psychiatry
Volume3
Paginatione256
Date Published2013
ISSN2158-3188
KeywordsAdaptor Proteins, Vesicular Transport, Aged, Alzheimer Disease, Amyloid beta-Protein Precursor, Case-Control Studies, Epistasis, Genetic, Genetic Predisposition to Disease, Humans, Oligonucleotide Array Sequence Analysis, Polymerase Chain Reaction, Polymorphism, Single Nucleotide, Receptors, Cell Surface, Receptors, Neuropeptide, Risk Factors
Abstract

Genetic variants in the sortilin-related receptor (SORL1) and the sortilin-related vacuolar protein sorting 10 (VPS10) domain-containing receptor 1 (SORCS1) are associated with increased risk of Alzheimer's disease (AD), declining cognitive function and altered amyloid precursor protein (APP) processing. We explored whether other members of the (VPS10) domain-containing receptor protein family (the sortilin-related VPS10 domain-containing receptors 2 and 3 (SORCS2 and SORCS3) and sortilin (SORT1)) would have similar effects either independently or together. We conducted the analyses in a large Caucasian case control data set (n=11,840 cases, 10,931 controls) to determine the associations between single nucleotide polymorphisms (SNPs) in all the five homologous genes and AD risk. Evidence for interactions between SNPs in the five VPS10 domain receptor family genes was determined in epistatic statistical models. We also compared expression levels of SORCS2, SORCS3 and SORT1 in AD and control brains using microarray gene expression analyses and assessed the effects of these genes on γ-secretase processing of APP. Several SNPs in SORL1, SORCS1, SORCS2 and SORCS3 were associated with AD. In addition, four specific linkage disequilibrium blocks in SORCS1, SORCS2 and SORCS3 showed additive epistatic effects on the risk of AD (P≤0.0006). SORCS3, but not SORCS2 or SORT1, showed reduced expression in AD compared with control brains, but knockdown of all the three genes using short hairpin RNAs in HEK293 cells caused a significant threefold increase in APP processing (from P<0.001 to P<0.05). These findings indicate that in addition to SORL1 and SORCS1, variants in other members of the VPS10 domain receptor family (that is, SORCS1, SORCS2, SORCS3) are associated with AD risk and alter APP processing. More importantly, the results indicate that variants within these genes have epistatic effects on AD risk.

DOI10.1038/tp.2013.13
Alternate JournalTransl Psychiatry
PubMed ID23673467
PubMed Central IDPMC3669917
Grant List089703 / / Wellcome Trust / United Kingdom
100140 / / Wellcome Trust / United Kingdom
AG010491 / AG / NIA NIH HHS / United States
AG019757 / AG / NIA NIH HHS / United States
AG021547 / AG / NIA NIH HHS / United States
AG025688 / AG / NIA NIH HHS / United States
AG027944 / AG / NIA NIH HHS / United States
AG030653 / AG / NIA NIH HHS / United States
K01 AG030514 / AG / NIA NIH HHS / United States
K23AG034550 / AG / NIA NIH HHS / United States
K24 AG027841 / AG / NIA NIH HHS / United States
MO1RR00096 / RR / NCRR NIH HHS / United States
P01 AG002219 / AG / NIA NIH HHS / United States
P01 AG03991 / AG / NIA NIH HHS / United States
P01AG019724 / AG / NIA NIH HHS / United States
P30 AG008017 / AG / NIA NIH HHS / United States
P30 AG008051 / AG / NIA NIH HHS / United States
P30 AG010129 / AG / NIA NIH HHS / United States
P30 AG010133 / AG / NIA NIH HHS / United States
P30 AG013846 / AG / NIA NIH HHS / United States
P30 AG019610 / AG / NIA NIH HHS / United States
P30 AG028377 / AG / NIA NIH HHS / United States
P30 AG08051 / AG / NIA NIH HHS / United States
P30 AG10133 / AG / NIA NIH HHS / United States
P30AG008017 / AG / NIA NIH HHS / United States
P30AG010124 / AG / NIA NIH HHS / United States
P30AG010161 / AG / NIA NIH HHS / United States
P30AG012300 / AG / NIA NIH HHS / United States
P30AG013854 / AG / NIA NIH HHS / United States
P30AG028383 / AG / NIA NIH HHS / United States
P50 AG005133 / AG / NIA NIH HHS / United States
P50 AG005134 / AG / NIA NIH HHS / United States
P50 AG005136 / AG / NIA NIH HHS / United States
P50 AG005138 / AG / NIA NIH HHS / United States
P50 AG005146 / AG / NIA NIH HHS / United States
P50 AG005681 / AG / NIA NIH HHS / United States
P50 AG008702 / AG / NIA NIH HHS / United States
P50 AG008702 / AG / NIA NIH HHS / United States
P50 AG016573 / AG / NIA NIH HHS / United States
P50 AG016574 / AG / NIA NIH HHS / United States
P50 AG016582 / AG / NIA NIH HHS / United States
P50AG005131 / AG / NIA NIH HHS / United States
P50AG005133 / AG / NIA NIH HHS / United States
P50AG005142 / AG / NIA NIH HHS / United States
P50AG008671 / AG / NIA NIH HHS / United States
P50AG016570 / AG / NIA NIH HHS / United States
P50AG016573 / AG / NIA NIH HHS / United States
P50AG016575 / AG / NIA NIH HHS / United States
P50AG016576 / AG / NIA NIH HHS / United States
P50AG016577 / AG / NIA NIH HHS / United States
P50AG023501 / AG / NIA NIH HHS / United States
R01 AG009029 / AG / NIA NIH HHS / United States
R01 AG017173 / AG / NIA NIH HHS / United States
R01 AG019085 / AG / NIA NIH HHS / United States
R01 AG020688 / AG / NIA NIH HHS / United States
R01 AG025259 / AG / NIA NIH HHS / United States
R01 AG026916 / AG / NIA NIH HHS / United States
R01 AG027944 / AG / NIA NIH HHS / United States
R01 AG031581 / AG / NIA NIH HHS / United States
R01 CA129769 / CA / NCI NIH HHS / United States
R01 HG002213 / HG / NHGRI NIH HHS / United States
R01 HG02213 / HG / NHGRI NIH HHS / United States
R01 MH080295 / MH / NIMH NIH HHS / United States
R01 NS059873 / NS / NINDS NIH HHS / United States
R01AG019085 / AG / NIA NIH HHS / United States
R01AG15819 / AG / NIA NIH HHS / United States
R01AG17917 / AG / NIA NIH HHS / United States
R01AG30146 / AG / NIA NIH HHS / United States
R37 AG015473 / AG / NIA NIH HHS / United States
RC2 AG036535 / AG / NIA NIH HHS / United States
RC2AG036528 / AG / NIA NIH HHS / United States
T35 HL007616 / HL / NHLBI NIH HHS / United States
U01 AG016976 / AG / NIA NIH HHS / United States
U01 AG024904 / AG / NIA NIH HHS / United States
U01 AG032984 / AG / NIA NIH HHS / United States
U01 AG06781 / AG / NIA NIH HHS / United States
U01 AG10483 / AG / NIA NIH HHS / United States
U01 HG004610 / HG / NHGRI NIH HHS / United States
U01AG016976 / AG / NIA NIH HHS / United States
U01AG032984 / AG / NIA NIH HHS / United States
U24 AG021886 / AG / NIA NIH HHS / United States
U24 AG026395 / AG / NIA NIH HHS / United States
U24AG021886 / AG / NIA NIH HHS / United States
U24AG026390 / AG / NIA NIH HHS / United States
UL1 RR029893 / RR / NCRR NIH HHS / United States
UL1RR02777 / RR / NCRR NIH HHS / United States
/ / Canadian Institutes of Health Research / Canada
/ / Howard Hughes Medical Institute / United States
/ / Wellcome Trust / United Kingdom